The FDA on Dec. 23 granted emergency use authorization for Merck’s COVID-19 pill molnupiravir, making it the second at-home antiviral treatment available for patients.
Read the full post on Becker's Hospital Review - Healthcare News
FDA authorizes Merck’s COVID-19 antiviral pill
